speb/financial-data huggingface dataset:
Financial ratios for BIR.TO — quarterly report dated 2025-06-30
Total revenue: 124967883.21167882
Gross profit: 69800000
Operating income: 17931386.86131387
Net income: -10142335.766423358
Capital expenditures: 329927.0072992701
Operating cash flow: 80012408.75912409
Depreciation & amortization: 46827737.22627737
Net tangible assets: 1633184671.5328467
Owner earnings: 36355474.45255474
Capex to operating income (%): 1.839941382398437
Buffett classification: The Great
Stock price: 5.357664233576642
P/E ratio: 41.03130194258048
Shares outstanding: 274329604
Book value: 1633184671.5328465
P/B ratio: 0.8999385881956484
Market cap (USD): 1469765907.5620437
Debt to equity: 0.2877374955474124
Current ratio: 1.46771039030981
Quick ratio: 1.46771039030981
COGS to revenue (%): 44.14564910108291
SG&A to revenue (%): 5.960071492821513
Free cash flow (dilution-adjusted): 79682481.75182481
Buyback yield (%): 0
Retained earnings: 492959854.0145985
Receivables turnover: 2.444647523310439
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7300287393468137
FCF margin (%): 63.76236814130346
Revenue growth (%): -15.680170904093366
Rule of 40 score: 48.082197237210096
Financial ratios for BIR.TO — quarterly report dated 2025-09-30
Total revenue: 108019424.46043167
Gross profit: 54577697.84172662
Operating income: 3194244.604316547
Net income: -10161870.503597124
Capital expenditures: 286330.9352517986
Operating cash flow: 56479136.69064748
Depreciation & amortization: 48369784.17266187
Net tangible assets: 1596060431.6546764
Owner earnings: 37921582.73381294
Capex to operating income (%): 8.963963963963964
Buffett classification: The Great
Stock price: 4.071942446043166
P/E ratio: 43.535058992169255
Shares outstanding: 274329604
Book value: 1596060431.6546764
P/B ratio: 0.6998822454208293
Market cap (USD): 1117054358.733813
Debt to equity: 0.28656845722651636
Current ratio: 1.2272717746667785
Quick ratio: 1.2272717746667785
Interest coverage ratio: 0.418433700876449
COGS to revenue (%): 49.474181968337696
SG&A to revenue (%): 6.2458790385422285
Free cash flow (dilution-adjusted): 56192805.75539569
Buyback yield (%): 0
Retained earnings: 469810071.94244605
Receivables turnover: 2.404583453444797
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.13312676696549228
FCF margin (%): 52.021019400987036
Revenue growth (%): -13.562251608710326
Rule of 40 score: 38.45876779227671
Financial ratios for BIR.TO — annual report dated 2025-12-31
Total revenue: 530439416.05839413
Gross profit: 232875912.40875912
Operating income: 85794160.5839416
Net income: 47353284.67153284
Capital expenditures: 223483211.6788321
Operating cash flow: 297594890.5109489
Depreciation & amortization: 190756204.37956202
Net tangible assets: 1638621167.8832116
Owner earnings: 14626277.372262746
Return on net tangible assets (%): 0.8925966330068303
Capex to operating income (%): 260.4876720720108
Buffett classification: The Gruesome
Stock price: 5.401459854014599
P/E ratio: 31.292028695625373
Shares outstanding: 274329604
Book value: 1638621167.8832116
P/B ratio: 0.9042848779305728
Market cap (USD): 1481780342.7737226
Debt to equity: 0.2756020171846456
Current ratio: 1.7386902302063836
Quick ratio: 1.7386902302063836
Effective tax rate (%): 22.134069495288962
Interest coverage ratio: 2.7527753056349242
COGS to revenue (%): 56.09754755044021
SG&A to revenue (%): 6.059842961764245
Free cash flow (dilution-adjusted): 74111678.83211678
Buyback yield (%): 0
Retained earnings: 490483211.67883205
Receivables turnover: 7.664177687780802
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5054902088268634
FCF margin (%): 13.971751832250359
Revenue growth (%): 18.34900572820589
Rule of 40 score: 32.320757560456244
Financial ratios for BIR.TO — quarterly report dated 2025-12-31
Total revenue: 141177372.26277372
Gross profit: 20556204.379562043
Operating income: 30250364.963503648
Net income: 19829927.007299267
Capital expenditures: 222385401.459854
Operating cash flow: 68237226.27737226
Depreciation & amortization: 49160583.941605836
Net tangible assets: 1638621167.8832116
Owner earnings: -153394890.5109489
Return on net tangible assets (%): -9.361217438018702
Capex to operating income (%): 735.1494824216394
Buffett classification: The Gruesome
Stock price: 5.401459854014599
P/E ratio: 32.57472113777539
Shares outstanding: 274329604
Book value: 1638621167.8832116
P/B ratio: 0.9042848779305728
Market cap (USD): 1481780342.7737226
Debt to equity: 0.2756020171846456
Current ratio: 1.7386902302063836
Quick ratio: 1.7386902302063836
Effective tax rate (%): 23.522788052810856
Interest coverage ratio: 4.3482320847759945
COGS to revenue (%): 85.43944822736837
SG&A to revenue (%): 7.01297224074907
Free cash flow (dilution-adjusted): -154148175.18248174
Buyback yield (%): 0
Retained earnings: 490483211.67883205
Receivables turnover: 2.0398342086945522
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2360090415390061
FCF margin (%): -109.18759338824174
Revenue growth (%): 30.696282606549218
Rule of 40 score: -78.49131078169252
Financial ratios for CANS.V — annual report dated 2021-12-31
Total revenue: 22268503.937007874
Gross profit: 1262992.125984252
Operating income: -11442519.68503937
Net income: -13685826.771653542
Capital expenditures: 2528346.4566929135
Operating cash flow: -12610236.22047244
Depreciation & amortization: 3014960.62992126
Net tangible assets: -9345669.291338583
Owner earnings: -13199212.598425196
Buffett classification: The Gruesome
Stock price: 0.4251968503937008
Shares outstanding: 100183769
Book value: 19267716.535433076
P/B ratio: 2.2108392014711886
Market cap (USD): 42597823.03937008
Debt to equity: 1.6879035553739268
Current ratio: 0.47588620515947716
Quick ratio: 0.19296338521091289
Interest coverage ratio: -8.987012987012987
COGS to revenue (%): 94.32834765390191
SG&A to revenue (%): 51.23227608641845
Free cash flow (dilution-adjusted): -15996850.393700786
Buyback yield (%): 0
Retained earnings: -18407086.61417323
Inventory turnover: 2.499953144035236
Receivables turnover: 6.717577197149644
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.15664561443258
FCF margin (%): -71.83621512676355
Rule of 40 score: -71.83621512676355
Financial ratios for CANS.V — annual report dated 2022-12-31
Total revenue: 26010294.117647056
Gross profit: -1899999.9999999998
Operating income: -15410294.117647057
Net income: -26944852.94117647
Capital expenditures: 292647.0588235294
Operating cash flow: -416176.47058823524
Depreciation & amortization: 5141911.764705882
Net tangible assets: -24769852.94117647
Owner earnings: -22095588.23529412
Buffett classification: The Gruesome
Stock price: 0.058823529411764705
Shares outstanding: 100183769
Book value: -6047058.823529407
Market cap (USD): 5893162.882352941
Debt to equity: -5.341074902723738
Current ratio: 0.43707093821510296
Quick ratio: 0.26083324252660633
Interest coverage ratio: -3.6976005645730416
COGS to revenue (%): 107.30480013569289
SG&A to revenue (%): 40.40255554927349
Free cash flow (dilution-adjusted): -965441.1764705882
Buyback yield (%): 0
Retained earnings: -44133823.52941176
Inventory turnover: 7.823165704863973
Receivables turnover: 6.502573529411765
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -80.07794589637778
FCF margin (%): -3.7117657036241307
Revenue growth (%): 16.80306046254291
Rule of 40 score: 13.091294758918778
Financial ratios for CANS.V — annual report dated 2023-12-31
Total revenue: 42655303.03030303
Gross profit: 2543939.393939394
Operating income: -12035606.06060606
Net income: -20390151.515151516
Capital expenditures: 1668939.3939393938
Operating cash flow: -13605303.03030303
Depreciation & amortization: 4657575.757575758
Net tangible assets: -33956818.18181818
Owner earnings: -17401515.151515152
Buffett classification: The Gruesome
Stock price: 0.03787878787878788
Shares outstanding: 100183769
Book value: -18630303.030303024
Market cap (USD): 3794839.734848485
Debt to equity: -2.60381424853611
Current ratio: 0.22666629018367662
Quick ratio: 0.1843966624782934
Interest coverage ratio: -1.7223547267996533
COGS to revenue (%): 94.03605363644436
SG&A to revenue (%): 26.242784832608113
Free cash flow (dilution-adjusted): -16628030.3030303
Buyback yield (%): 0
Retained earnings: -65861363.63636363
Inventory turnover: 17.68436873747495
Receivables turnover: 4.965167548500882
Capitalized R&D asset: 0
FCF margin (%): -38.982328390018644
Revenue growth (%): 63.99392808619927
Rule of 40 score: 25.011599696180625
Financial ratios for CANS.V — quarterly report dated 2024-09-30
Total revenue: 11950370.37037037
Gross profit: -232592.59259259258
Operating income: -3739259.259259259
Net income: -12600740.74074074
Capital expenditures: 87407.4074074074
Operating cash flow: -4888888.888888889
Depreciation & amortization: 1190370.3703703703
Net tangible assets: -54114814.81481481
Owner earnings: -11497777.777777776
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 100183769
Book value: -41271851.85185184
Market cap (USD): 0
Debt to equity: -1.5559524023188616
Current ratio: 0.16829113042786387
Quick ratio: 0.13398842320927734
Interest coverage ratio: -1.5652713178294575
COGS to revenue (%): 101.94632120498358
SG&A to revenue (%): 20.19463212049836
Free cash flow (dilution-adjusted): -5094814.814814814
Retained earnings: -88791111.1111111
Inventory turnover: 4.7686285879965205
Receivables turnover: 1.4614548419240874
Capitalized R&D asset: 0
FCF margin (%): -42.633112254385416
Rule of 40 score: -42.633112254385416
Financial ratios for CANS.V — quarterly report dated 2024-12-31
Total revenue: 9923776.223776225
Gross profit: -1398601.3986013986
Operating income: -4926573.426573426
Net income: -13095104.895104896
Capital expenditures: 54545.45454545455
Operating cash flow: -2493006.993006993
Depreciation & amortization: 1083916.083916084
Net tangible assets: -59406993.00699301
Owner earnings: -12065734.265734268
Buffett classification: The Gruesome
Stock price: 0.006993006993006994
Shares outstanding: 100183769
Book value: -50882517.48251749
Market cap (USD): 700585.7972027973
Debt to equity: -1.308155355817597
Current ratio: 0.13775664458675754
Quick ratio: 0.09599721481644358
Interest coverage ratio: -1.8054843669912863
COGS to revenue (%): 114.09343950391091
SG&A to revenue (%): 31.14650130364315
Free cash flow (dilution-adjusted): -2660839.160839161
Buyback yield (%): 0
Retained earnings: -96918881.11888112
Inventory turnover: 3.5522158841597196
Receivables turnover: 1.6518449540216507
Capitalized R&D asset: 0
FCF margin (%): -26.81276865619054
Revenue growth (%): -16.95842123536909
Rule of 40 score: -43.77118989155963
Financial ratios for CANS.V — annual report dated 2024-12-31
Total revenue: 38686713.28671329
Gross profit: -1816083.916083916
Operating income: -15031468.531468533
Net income: -36123776.22377623
Capital expenditures: 145454.54545454547
Operating cash flow: -6496503.496503497
Depreciation & amortization: 4495104.895104895
Net tangible assets: -59406993.00699301
Owner earnings: -31774125.87412588
Buffett classification: The Gruesome
Stock price: 0.006993006993006994
Shares outstanding: 100183769
Book value: -50882517.48251749
Market cap (USD): 700585.7972027973
Debt to equity: -1.308155355817597
Current ratio: 0.13775664458675754
Quick ratio: 0.09599721481644358
Interest coverage ratio: -1.6019526009837532
COGS to revenue (%): 104.6943349842739
SG&A to revenue (%): 26.794042153212104
Free cash flow (dilution-adjusted): -7201398.601398602
Buyback yield (%): 0
Retained earnings: -96918881.11888112
Inventory turnover: 12.707108380868803
Receivables turnover: 6.439529740426027
Capitalized R&D asset: 0
FCF margin (%): -18.614656013882364
Revenue growth (%): -9.303860157247957
Rule of 40 score: -27.91851617113032
Financial ratios for CANS.V — quarterly report dated 2025-03-31
Total revenue: 12096503.496503497
Gross profit: 407692.3076923077
Operating income: -2104195.804195804
Net income: -5280419.58041958
Capital expenditures: 32867.13286713287
Operating cash flow: -984615.3846153846
Depreciation & amortization: 1016783.2167832168
Net tangible assets: -64399300.6993007
Owner earnings: -4296503.496503497
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 100183769
Book value: -56102797.202797204
Market cap (USD): 0
Debt to equity: -1.2607351639722288
Current ratio: 0.13307341537351755
Quick ratio: 0.09730607057287864
Interest coverage ratio: -0.7369581190301249
COGS to revenue (%): 96.63544918487686
SG&A to revenue (%): 15.290785061856862
Free cash flow (dilution-adjusted): -1090209.7902097902
Retained earnings: -102199300.6993007
Inventory turnover: 4.0134453781512605
Receivables turnover: 1.8734972381674426
Capitalized R&D asset: 0
FCF margin (%): -9.012602613018846
Revenue growth (%): 21.894158269325615
Rule of 40 score: 12.88155565630677
Financial ratios for CANS.V — quarterly report dated 2025-06-30
Total revenue: 12545255.474452553
Gross profit: 296350.3649635036
Operating income: -1956204.3795620436
Net income: -5232846.715328467
Capital expenditures: 0
Operating cash flow: 362773.7226277372
Depreciation & amortization: 1088321.1678832115
Net tangible assets: -73813868.61313868
Owner earnings: -4144525.5474452553
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 100183769
Book value: -65394160.583941594
Market cap (USD): 0
Debt to equity: -1.1952003571827214
Current ratio: 0.13514302163266273
Quick ratio: 0.08491391887948643
Interest coverage ratio: -0.6317774634606317
COGS to revenue (%): 97.63774946180253
SG&A to revenue (%): 12.491999767265957
Free cash flow (dilution-adjusted): 361313.8686131387
Retained earnings: -111908759.12408759
Inventory turnover: 2.634793531166588
Receivables turnover: 2.004782456549633
Capitalized R&D asset: 0
FCF margin (%): 2.8800837842555422
Revenue growth (%): 3.709766033455609
Rule of 40 score: 6.589849817711151
Financial ratios for CD2.AX — annual report dated 2022-03-31
Total revenue: -276952
Net income: 22652782
Capital expenditures: 0
Net tangible assets: 104653586
Owner earnings: 22652782
Return on net tangible assets (%): 21.64549048515165
Buffett classification: The Gruesome
Stock price: 0.2631578947368421
P/E ratio: 0.6096507611945272
Shares outstanding: 52479086
Book value: 104654002
P/B ratio: 0.13196137295804208
Market cap (USD): 13810285.789473683
Debt to equity: 0
Effective tax rate (%): 11.34453010289777
Free cash flow (dilution-adjusted): -913823
Buyback yield (%): 22.961030990516875
Retained earnings: 20772558
Receivables turnover: -10.151827279058686
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CD2.AX — annual report dated 2023-03-31
Total revenue: 358833
Net income: -2441739
Capital expenditures: 0
Net tangible assets: 83379498
Owner earnings: -2441739
Return on net tangible assets (%): -2.9284645009496217
Buffett classification: The Gruesome
Stock price: 0.21476510067114093
Shares outstanding: 52479086
Book value: 83379498
P/B ratio: 0.13517323152892408
Market cap (USD): 11270676.187919462
Debt to equity: 0
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -1441243
Buyback yield (%): 9.100660713679352
Retained earnings: 487930
Receivables turnover: 11.251152290471262
Capitalized R&D asset: 0
FCF margin (%): -401.6472843913464
Rule of 40 score: -401.6472843913464
Financial ratios for CD2.AX — annual report dated 2024-03-31
Total revenue: 145740
Net income: 10472745
Capital expenditures: 0
Net tangible assets: 80994865
Owner earnings: 10472745
Return on net tangible assets (%): 12.93013452149096
Buffett classification: The Gruesome
Stock price: 0.26143790849673204
P/E ratio: 1.3100693737563678
Shares outstanding: 52479086
Book value: 80994865
P/B ratio: 0.16939373235155256
Market cap (USD): 13720022.483660132
Debt to equity: 0
Effective tax rate (%): 15.923003730852006
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -993817
Buyback yield (%): 0
Retained earnings: -1896703
Receivables turnover: 6.004696963454328
Capitalized R&D asset: 0
FCF margin (%): -681.910937285577
Revenue growth (%): -59.38500639573283
Rule of 40 score: -741.2959436813098
Financial ratios for CD2.AX — quarterly report dated 2024-09-30
Total revenue: -7445564
Net income: -8340169
Capital expenditures: 0
Net tangible assets: 68981160
Owner earnings: -8340169
Return on net tangible assets (%): -12.090502682181627
Buffett classification: The Gruesome
Stock price: 0.2482758620689655
Shares outstanding: 52479086
Book value: 68981160
P/B ratio: 0.18888186741483298
Market cap (USD): 13029290.31724138
Debt to equity: 0
Free cash flow (dilution-adjusted): -1923327
Buyback yield (%): 0
Retained earnings: -13910408
Receivables turnover: -159.72463799206264
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CD2.AX — annual report dated 2025-03-31
Total revenue: 279061
Net income: 207764
Capital expenditures: 0
Net tangible assets: 72805975
Owner earnings: 207764
Return on net tangible assets (%): 0.2853666886543309
Buffett classification: The Gruesome
Stock price: 0.23270440251572325
P/E ratio: 58.778779539291016
Shares outstanding: 52479086
Book value: 72805975
P/B ratio: 0.16773505680270412
Market cap (USD): 12212114.352201257
Debt to equity: 0
Effective tax rate (%): 93.21768538709635
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -2248555
Buyback yield (%): 0
Retained earnings: -10085593
Receivables turnover: 13.126722799755397
Capitalized R&D asset: 0
FCF margin (%): -805.7575225488333
Revenue growth (%): 91.47866062851654
Rule of 40 score: -714.2788619203168
Financial ratios for CGF.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.3909774436090223
Shares outstanding: 681584902
Market cap (USD): 2311239028.586466
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGF.AX — annual report dated 2022-06-30
Total revenue: 711103448.2758621
Gross profit: 938275862.0689656
Operating income: -353379310.3448276
Net income: 174965517.24137932
Capital expenditures: 2000000
Depreciation & amortization: 9655172.413793104
Net tangible assets: 2345586206.8965516
Owner earnings: 182620689.65517244
Return on net tangible assets (%): 7.785716385875159
Buffett classification: The Gruesome
Stock price: 4.062068965517241
P/E ratio: 15.823945891919587
Shares outstanding: 681584902
Book value: 2750551724.137932
P/B ratio: 1.0065780088709473
Market cap (USD): 2768644877.77931
Debt to equity: 1.4656620615299747
Current ratio: 2.8441549469528744
Quick ratio: 2.8441549469528744
Effective tax rate (%): 28.99524209347887
Interest coverage ratio: -11.13913043478261
COGS to revenue (%): -31.946464940354964
SG&A to revenue (%): 21.268548152458543
Free cash flow (dilution-adjusted): 1713034482.7586207
Buyback yield (%): 0.044837072472093994
Retained earnings: 1073172413.7931035
Receivables turnover: 1.5924324324324324
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.615259765116599
FCF margin (%): 240.89807002230629
Rule of 40 score: 240.89807002230629
Financial ratios for CGF.AX — annual report dated 2023-06-30
Total revenue: 1073112582.781457
Gross profit: 431920529.8013245
Operating income: -579536423.8410596
Net income: 190397350.99337748
Capital expenditures: 5231788.079470199
Depreciation & amortization: 9602649.006622516
Net tangible assets: 2366225165.562914
Owner earnings: 194768211.9205298
Return on net tangible assets (%): 8.231178281556115
Buffett classification: The Gruesome
Stock price: 3.821192052980132
P/E ratio: 13.67911264187826
Shares outstanding: 681584902
Book value: 2757880794.701988
P/B ratio: 0.9443725109355484
Market cap (USD): 2604466810.9536424
Debt to equity: 1.4146815867832094
Current ratio: 2.938286674022791
Quick ratio: 2.938286674022791
Effective tax rate (%): 27.573529411764707
Interest coverage ratio: -1.5931185144729654
COGS to revenue (%): 59.7506788447297
SG&A to revenue (%): 13.342384596395954
Free cash flow (dilution-adjusted): 838211920.5298014
Buyback yield (%): 0.6509448426374178
Retained earnings: 1114635761.5894039
Receivables turnover: 2.324487161095969
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.228128578399872
FCF margin (%): 78.11034312515429
Revenue growth (%): 50.90808311833115
Rule of 40 score: 129.01842624348544
Financial ratios for CGF.AX — annual report dated 2024-06-30
Total revenue: 1322666666.6666667
Gross profit: 423933333.3333333
Operating income: -941000000
Net income: 86600000
Capital expenditures: 1266666.6666666667
Depreciation & amortization: 9200000
Net tangible assets: 2197800000
Owner earnings: 94533333.33333333
Return on net tangible assets (%): 4.301270967937635
Buffett classification: The Gruesome
Stock price: 4.3133333333333335
P/E ratio: 33.94807017659738
Shares outstanding: 681584902
Book value: 2590133333.333336
P/B ratio: 1.1350392041439297
Market cap (USD): 2939902877.2933335
Debt to equity: 1.8340368578194155
Current ratio: 2.910615025999641
Quick ratio: 2.910615025999641
Effective tax rate (%): 29.129287598944593
Interest coverage ratio: -1.8410069127429243
COGS to revenue (%): 67.94858870967742
SG&A to revenue (%): 11.547379032258064
Free cash flow (dilution-adjusted): 561200000
Buyback yield (%): 0.33107669673409335
Retained earnings: 924933333.3333334
Receivables turnover: 2.2292134831460673
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.342993497476733
FCF margin (%): 42.42943548387096
Revenue growth (%): 23.255163334156183
Rule of 40 score: 65.68459881802714
Financial ratios for CHNR — annual report dated 2021-12-31
Gross profit: 37833.59497645212
Capital expenditures: 23704.866562009418
Buffett classification: The Gruesome
Stock price: 23.2
Shares outstanding: 1256388
Market cap (USD): 29148201.599999998
Buyback yield (%): 0
Inventory turnover: 18.756592292089252
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHNR — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 836350.5747126436
Operating income: -3627586.206896552
Net income: -3203448.275862069
Capital expenditures: 33908.0459770115
Operating cash flow: -1837068.9655172413
Depreciation & amortization: 363505.7471264368
Net tangible assets: 6952298.850574712
Owner earnings: -2873850.5747126434
Return on net tangible assets (%): -41.3366950483591
Buffett classification: The Gruesome
Stock price: 15.2
Shares outstanding: 1256388
Book value: 25495545.977011494
P/B ratio: 0.7490366206402966
Market cap (USD): 19097097.599999998
Debt to equity: 0.4334484837897086
Current ratio: 3.0456485433290035
Quick ratio: 3.034375579884951
Interest coverage ratio: -6.288418430884184
Free cash flow (dilution-adjusted): -4193678.16091954
Buyback yield (%): 0
Retained earnings: -159340517.24137932
Inventory turnover: 19.86968449931413
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.88865084618307
Rule of 40 score: 0
Financial ratios for CHNR — annual report dated 2023-12-31
Total revenue: 0
Operating income: -1811954.9929676512
Net income: -1750070.323488045
Capital expenditures: 1687.7637130801686
Operating cash flow: 1874542.8973277074
Depreciation & amortization: 226441.63150492264
Net tangible assets: 10688466.947960619
Owner earnings: -1525316.4556962026
Return on net tangible assets (%): -14.27067570234884
Buffett classification: The Gruesome
Stock price: 12.72
Shares outstanding: 1256388
Book value: 10688466.947960615
P/B ratio: 1.4951868624198967
Market cap (USD): 15981255.360000001
Debt to equity: 0.0047371537601157985
Current ratio: 0.033057386453107775
Quick ratio: 0.033057386453107775
Interest coverage ratio: -268.39583333333337
Free cash flow (dilution-adjusted): 1440506.329113924
Buyback yield (%): 0
Retained earnings: -157925597.74964836
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.952431080992177
Rule of 40 score: 0
Financial ratios for CHNR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 12063287.671232877
Buffett classification: The Gruesome
Stock price: 5.44
Shares outstanding: 1256388
Book value: 12063287.671232875
P/B ratio: 0.5665744618109969
Market cap (USD): 6834750.720000001
Debt to equity: 0
Current ratio: 0.25157377995957264
Quick ratio: 0.25157377995957264
Buyback yield (%): 0
Retained earnings: -154248082.19178084
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHNR — annual report dated 2024-12-31
Total revenue: 0
Operating income: -986164.3835616439
Net income: -432876.7123287671
Capital expenditures: 136.986301369863
Operating cash flow: -1016027.397260274
Depreciation & amortization: 47945.20547945206
Net tangible assets: 12063287.671232877
Owner earnings: -385068.4931506849
Return on net tangible assets (%): -3.192069223955849
Buffett classification: The Gruesome
Stock price: 5.44
Shares outstanding: 1256388
Book value: 12063287.671232875
P/B ratio: 0.5665744618109969
Market cap (USD): 6834750.720000001
Debt to equity: 0
Current ratio: 0.25157377995957264
Quick ratio: 0.25157377995957264
Interest coverage ratio: -257.1071428571429
Free cash flow (dilution-adjusted): -1033698.6301369863
Buyback yield (%): 0
Retained earnings: -154248082.19178084
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.9555699705223057
Rule of 40 score: 0
Financial ratios for CHNR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 12063319.386331938
Buffett classification: The Gruesome
Stock price: 3.94
Shares outstanding: 1256388
Book value: 12063319.386331942
P/B ratio: 0.410348807112632
Market cap (USD): 4950168.72
Debt to equity: 0
Current ratio: 0.1473292469352014
Quick ratio: 0.1473292469352014
Buyback yield (%): 0
Retained earnings: -157222454.67224547
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLG.AX — annual report dated 2022-06-30
Total revenue: 48366896.551724136
Gross profit: 14506206.896551725
Operating income: 2631724.1379310344
Net income: 3176551.724137931
Capital expenditures: 411034.4827586207
Net tangible assets: 15855862.068965517
Owner earnings: 2765517.2413793104
Return on net tangible assets (%): 17.441607585576964
Capex to operating income (%): 15.618448637316561
Buffett classification: The Great
Stock price: 0.2827586206896552
P/E ratio: 52.88348788970907
Shares outstanding: 594100842
Book value: 36708965.51724138
P/B ratio: 4.576188194559254
Market cap (USD): 167987134.63448277
Debt to equity: 0.45524911700608706
Current ratio: 1.8767232486167118
Quick ratio: 1.6224327112444903
Effective tax rate (%): -54.502688172043015
Interest coverage ratio: 9.516209476309227
COGS to revenue (%): 70.00798494267953
SG&A to revenue (%): 13.242171904408831
Free cash flow (dilution-adjusted): -2582068.9655172415
Buyback yield (%): 0
Retained earnings: 8348275.862068966
Inventory turnover: 9.053660335607598
Receivables turnover: 3.327260650915646
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.379345343821364
FCF margin (%): -5.338504534306736
Rule of 40 score: -5.338504534306736
Financial ratios for CLG.AX — annual report dated 2023-06-30
Total revenue: 90022516.55629139
Gross profit: 31519867.549668875
Operating income: 10227814.569536423
Net income: 8104635.761589404
Capital expenditures: 10413245.033112582
Depreciation & amortization: 4596026.490066225
Net tangible assets: -5116556.291390728
Owner earnings: 2287417.218543047
Return on net tangible assets (%): -44.70618690137201
Capex to operating income (%): 101.81300181300182
Buffett classification: The Gruesome
Stock price: 0.32450331125827814
P/E ratio: 23.787335559731982
Shares outstanding: 594100842
Book value: 82158940.39735098
P/B ratio: 2.3465211396098664
Market cap (USD): 192787690.45033112
Debt to equity: 0.8935756891826537
Current ratio: 1.7956927307863833
Quick ratio: 1.5007061097071503
Effective tax rate (%): 17.760903165109873
Interest coverage ratio: 6.321735571019238
COGS to revenue (%): 64.98668471464093
SG&A to revenue (%): 18.546500507599276
Free cash flow (dilution-adjusted): 4605298.013245033
Buyback yield (%): 0
Retained earnings: 16036423.841059603
Inventory turnover: 5.564661417322835
Receivables turnover: 5.198638519198409
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.098633499262283
FCF margin (%): 5.115717921932703
Revenue growth (%): 86.12423573635789
Rule of 40 score: 91.23995365829059
Financial ratios for CLG.AX — annual report dated 2024-06-30
Total revenue: 141974666.66666666
Gross profit: 53362000
Operating income: 12228000
Net income: 7444000
Capital expenditures: 6727333.333333333
Depreciation & amortization: 14046000
Net tangible assets: -1268666.6666666667
Owner earnings: 14762666.666666668
Return on net tangible assets (%): -1163.6363636363637
Capex to operating income (%): 55.015810707665466
Buffett classification: The Good
Stock price: 0.22666666666666668
P/E ratio: 18.090120569586244
Shares outstanding: 594100842
Book value: 94358000.00000001
P/B ratio: 1.4271482812268168
Market cap (USD): 134662857.52
Debt to equity: 0.7677003186445946
Current ratio: 2.191271113844532
Quick ratio: 1.7531574669976058
Effective tax rate (%): 20.81974188058431
Interest coverage ratio: 1.9144139442646906
COGS to revenue (%): 62.41442135216613
SG&A to revenue (%): 19.079460185385187
Free cash flow (dilution-adjusted): 7750666.666666667
Buyback yield (%): 0
Retained earnings: 23444666.666666668
Inventory turnover: 6.6639426451418835
Receivables turnover: 5.8000926001579645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.2937667760214735
FCF margin (%): 5.4591899024239074
Revenue growth (%): 57.71017307418796
Rule of 40 score: 63.16936297661187
Financial ratios for CLIK — annual report dated 2024-12-31
Total revenue: 1030148.0670103093
Gross profit: 243510.05154639177
Operating income: 122944.07216494846
Net income: 120592.65463917526
Capital expenditures: 0
Owner earnings: 120592.65463917526
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 35.7
P/E ratio: 2201.333912038803
Shares outstanding: 7435986
Market cap (USD): 265464700.20000002
Effective tax rate (%): 11.788227420335486
Interest coverage ratio: 32.825695017891555
COGS to revenue (%): 76.36164553964504
SG&A to revenue (%): 11.70375242574102
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -81.80029732267975
Rule of 40 score: -81.80029732267975
Financial ratios for CLIK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5265404.789948454
Buffett classification: The Gruesome
Stock price: 35.7
Shares outstanding: 7435986
Book value: 5265404.789948454
P/B ratio: 50.416769610337745
Market cap (USD): 265464700.20000002
Debt to equity: 0.08653511637071572
Current ratio: 4.503412714043149
Quick ratio: 4.503412714043149
Buyback yield (%): 0
Retained earnings: 951586.0012886599
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLIK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 135116.94267515925
Buffett classification: The Gruesome
Stock price: 12.57
Shares outstanding: 7435986
Book value: 15463318.47133758
P/B ratio: 6.044649742760863
Market cap (USD): 93470344.02
Debt to equity: 0.04828403853623595
Current ratio: 2.960758398516943
Quick ratio: 2.960758398516943
Buyback yield (%): 0
Retained earnings: -530537.1974522293
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLIK — annual report dated 2025-06-30
Total revenue: 10643170.955414014
Gross profit: 1629948.4076433121
Operating income: -1085167.643312102
Net income: -1010653.1210191083
Capital expenditures: 46913.12101910828
Operating cash flow: -760854.7770700637
Depreciation & amortization: 58505.35031847134
Net tangible assets: 135116.94267515925
Owner earnings: -999060.8917197452
Return on net tangible assets (%): -739.4046016284077
Buffett classification: The Gruesome
Stock price: 12.57
Shares outstanding: 7435986
Book value: 15463318.47133758
P/B ratio: 6.044649742760863
Market cap (USD): 93470344.02
Debt to equity: 0.04828403853623595
Current ratio: 2.960758398516943
Quick ratio: 2.960758398516943
Interest coverage ratio: -28.912365850512842
COGS to revenue (%): 84.6855000782057
SG&A to revenue (%): 25.510405332484844
Free cash flow (dilution-adjusted): -2259066.1146496814
Buyback yield (%): 0
Retained earnings: -530537.1974522293
Receivables turnover: 4.498073582245473
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.527921959257392
FCF margin (%): -21.225498717565277
Revenue growth (%): 933.1690459122613
Rule of 40 score: 911.943547194696
Financial ratios for CLMT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.2
Shares outstanding: 87147147
Market cap (USD): 1150342340.3999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLMT — annual report dated 2022-12-31
Total revenue: 4686300000
Gross profit: 351700000
Operating income: 132600000
Net income: -169800000
Capital expenditures: 536000000
Operating cash flow: 100600000
Depreciation & amortization: 98300000
Net tangible assets: -209300000
Owner earnings: -607500000
Capex to operating income (%): 404.2232277526395
Buffett classification: The Gruesome
Stock price: 16.88
Shares outstanding: 87147147
Book value: -287700000
Market cap (USD): 1471043841.36
Debt to equity: -5.795968022245394
Current ratio: 0.606706640017766
Quick ratio: 0.238285587386187
Interest coverage ratio: 0.7538374076179648
COGS to revenue (%): 92.49514542389518
SG&A to revenue (%): 4.210144463649361
Free cash flow (dilution-adjusted): -452900000
Buyback yield (%): 0.2991073329216443
Inventory turnover: 8.709262607996786
Receivables turnover: 17.545114189442156
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.538882094813323
FCF margin (%): -9.664340737895568
Rule of 40 score: -9.664340737895568
Financial ratios for CLMT — annual report dated 2023-12-31
Total revenue: 4181000000
Gross profit: 451700000
Operating income: 270700000
Net income: 48100000
Capital expenditures: 271800000
Operating cash flow: -14900000
Depreciation & amortization: 146800000
Net tangible assets: -201500000
Owner earnings: -76900000
Capex to operating income (%): 100.40635389730328
Buffett classification: The Gruesome
Stock price: 17.87
P/E ratio: 32.37670513284824
Shares outstanding: 87147147
Book value: -244700000
Market cap (USD): 1557319516.89
Debt to equity: -8.173273395995096
Current ratio: 0.714208681585333
Quick ratio: 0.3193133818639346
Effective tax rate (%): 3.2193158953722336
Interest coverage ratio: 1.221019395579612
COGS to revenue (%): 89.19636450609903
SG&A to revenue (%): 4.494140157856972
Free cash flow (dilution-adjusted): -301400000
Buyback yield (%): 0
Retained earnings: 0
Inventory turnover: 8.487255348202094
Receivables turnover: 14.608665269042628
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.520200170877576
FCF margin (%): -7.208801722076058
Revenue growth (%): -10.78249365170817
Rule of 40 score: -17.99129537378423
Financial ratios for CLMT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.82
Shares outstanding: 87147147
Market cap (USD): 1552962159.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLMT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.02
Shares outstanding: 87147147
Market cap (USD): 1918980176.94
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLMT — annual report dated 2024-12-31
Total revenue: 4189400000
Gross profit: 230800000
Operating income: 10100000
Net income: -222000000
Capital expenditures: 76700000
Operating cash flow: -46400000
Depreciation & amortization: 149000000
Net tangible assets: -906900000
Owner earnings: -149700000
Capex to operating income (%): 759.4059405940594
Buffett classification: The Gruesome
Stock price: 22.02
Shares outstanding: 87147147
Book value: -466300000
Market cap (USD): 1918980176.94
Debt to equity: -5.020802058760455
Current ratio: 0.8869847151459008
Quick ratio: 0.4049328392774433
Interest coverage ratio: 0.04267004647232784
COGS to revenue (%): 94.49085787940994
SG&A to revenue (%): 4.80259703060104
Free cash flow (dilution-adjusted): -137700000
Buyback yield (%): 0
Retained earnings: -1539000000
Inventory turnover: 9.50900792697574
Receivables turnover: 15.064365336209997
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5330940567929906
FCF margin (%): -3.2868668544421635
Revenue growth (%): 0.20090887347524516
Rule of 40 score: -3.0859579809669184
Financial ratios for CLMT — quarterly report dated 2025-03-31
Total revenue: 993900000
Gross profit: -81400000
Operating income: -110900000
Net income: -162000000
Capital expenditures: 17600000
Operating cash flow: -29300000
Depreciation & amortization: 37000000
Net tangible assets: -862300000
Owner earnings: -142600000
Buffett classification: The Gruesome
Stock price: 12.68
Shares outstanding: 87147147
Book value: -616700000
Market cap (USD): 1105025823.96
Debt to equity: -3.771850170261067
Current ratio: 1.0561500402715454
Quick ratio: 0.608100333678518
Interest coverage ratio: -1.8957264957264957
COGS to revenue (%): 108.18995874836503
SG&A to revenue (%): 2.4549753496327598
Free cash flow (dilution-adjusted): -25400000
Buyback yield (%): 0
Retained earnings: -1701000000
Inventory turnover: 2.7614278376990242
Receivables turnover: 3.278034300791557
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.674085443847531
FCF margin (%): -2.5555890934701684
Rule of 40 score: -2.5555890934701684
Financial ratios for CLMT — quarterly report dated 2025-06-30
Total revenue: 1026600000
Gross profit: -43600000
Operating income: -101000000
Net income: -147900000
Capital expenditures: 13600000
Operating cash flow: -1800000
Net tangible assets: -1009700000
Owner earnings: -161500000
Buffett classification: The Gruesome
Stock price: 15.76
Shares outstanding: 87147147
Book value: -764100000
Market cap (USD): 1373439036.72
Debt to equity: -3.0588928150765606
Current ratio: 0.761734693877551
Quick ratio: 0.44668367346938775
Interest coverage ratio: -1.9092627599243857
COGS to revenue (%): 104.24702902785896
SG&A to revenue (%): 5.191895577634911
Free cash flow (dilution-adjusted): -15400000
Buyback yield (%): 0
Retained earnings: -1848900000
Inventory turnover: 2.888529014844804
Receivables turnover: 3.3559986923831318
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.310922269432642
FCF margin (%): -1.5000974089226573
Revenue growth (%): 3.290069423483248
Rule of 40 score: 1.7899720145605906
Financial ratios for CLMT — quarterly report dated 2025-09-30
Total revenue: 1078000000
Gross profit: 373700000
Operating income: 329300000
Net income: 313400000
Capital expenditures: 8400000
Operating cash flow: 23500000
Net tangible assets: -695300000
Owner earnings: 305000000
Return on net tangible assets (%): -43.86595714080253
Capex to operating income (%): 2.550865472213787
Buffett classification: The Great
Stock price: 18.25
P/E ratio: 454.4101236428571
Shares outstanding: 87147147
Book value: -449700000
Market cap (USD): 1590435432.75
Debt to equity: -5.1203024238381145
Current ratio: 1.1337111941259823
Quick ratio: 0.6183176606981837
Effective tax rate (%): -15.220588235294116
Interest coverage ratio: 6.143656716417911
COGS to revenue (%): 65.33395176252318
SG&A to revenue (%): 3.9239332096474957
Free cash flow (dilution-adjusted): 15100000
Buyback yield (%): 0
Retained earnings: -1535500000
Inventory turnover: 1.7603099225193701
Receivables turnover: 3.8679583781844276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.821618308132408
FCF margin (%): 1.4007421150278292
Revenue growth (%): 5.006818624586011
Rule of 40 score: 6.4075607396138405
Financial ratios for CLMT — annual report dated 2025-12-31
Total revenue: 4137100000
Gross profit: 245700000
Operating income: 54200000
Net income: -33800000
Capital expenditures: 52300000
Operating cash flow: 108900000
Depreciation & amortization: 148800000
Net tangible assets: -881900000
Owner earnings: 62700000
Capex to operating income (%): 96.49446494464945
Buffett classification: The Gruesome
Stock price: 19.87
Shares outstanding: 87147147
Book value: -487100000
Market cap (USD): 1731613810.89
Debt to equity: -5.048450010264832
Current ratio: 1.0203401926965623
Quick ratio: 0.5621505887950518
Interest coverage ratio: 0.2511584800741427
COGS to revenue (%): 94.06105726233352
SG&A to revenue (%): 4.150250175243528
Free cash flow (dilution-adjusted): 61100000
Buyback yield (%): 0
Retained earnings: -1573400000
Inventory turnover: 10.102284527518172
Receivables turnover: 17.793978494623655
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9325830537820585
FCF margin (%): 1.4768799400546275
Revenue growth (%): -1.2483887907576263
Rule of 40 score: 0.2284911492970012
Financial ratios for CLMT — quarterly report dated 2025-12-31
Total revenue: 1038600000
Gross profit: -3000000
Operating income: -63200000
Net income: -37300000
Capital expenditures: 12700000
Operating cash flow: 116500000
Net tangible assets: -881900000
Owner earnings: -50000000
Buffett classification: The Gruesome
Stock price: 19.87
Shares outstanding: 87147147
Book value: -487100000
Market cap (USD): 1731613810.89
Debt to equity: -5.048450010264832
Current ratio: 1.0203401926965623
Quick ratio: 0.5621505887950518
Interest coverage ratio: -1.2440944881889764
COGS to revenue (%): 100.28885037550548
SG&A to revenue (%): 4.977854804544579
Free cash flow (dilution-adjusted): 103800000
Buyback yield (%): 0
Retained earnings: -1573400000
Inventory turnover: 2.70404984423676
Receivables turnover: 4.467096774193548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.419543339465426
FCF margin (%): 9.99422299248989
Revenue growth (%): -3.6549165120593687
Rule of 40 score: 6.339306480430521
Financial ratios for CNU.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.5037593984962405
Shares outstanding: 433887294
Market cap (USD): 1520236684.2406015
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNU.AX — annual report dated 2022-06-30
Total revenue: 599378881.9875776
Gross profit: 599378881.9875776
Operating income: 191925465.8385093
Net income: 39751552.795031056
Capital expenditures: 321739130.43478256
Depreciation & amortization: 227329192.54658383
Net tangible assets: 544720496.8944099
Owner earnings: -54658385.09316766
Return on net tangible assets (%): -10.034207525655638
Capex to operating income (%): 167.63754045307445
Buffett classification: The Gruesome
Stock price: 3.627586206896552
P/E ratio: 39.59502088328018
Shares outstanding: 433887294
Book value: 639130434.7826085
P/B ratio: 2.4626640782603806
Market cap (USD): 1573963563.062069
Debt to equity: 2.4382896015549083
Current ratio: 0.5040485829959513
Quick ratio: 0.5040485829959513
Effective tax rate (%): 39.62264150943396
Interest coverage ratio: 2.176056338028169
COGS to revenue (%): 0
SG&A to revenue (%): 9.22279792746114
Free cash flow (dilution-adjusted): 32298136.64596273
Buyback yield (%): 1.499557234103451
Retained earnings: 178260869.56521738
Receivables turnover: 7.72
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.773542600896861
FCF margin (%): 5.3886010362694305
Rule of 40 score: 5.3886010362694305
Financial ratios for CNU.AX — annual report dated 2023-06-30
Total revenue: 593939393.939394
Gross profit: 593939393.939394
Operating income: 136969696.96969697
Net income: 15151515.151515152
Capital expenditures: 300000000
Depreciation & amortization: 270303030.3030303
Net tangible assets: 519393939.39393944
Owner earnings: -14545454.545454562
Return on net tangible assets (%): -2.8004667444574123
Capex to operating income (%): 219.02654867256638
Buffett classification: The Gruesome
Stock price: 4.3841059602649
P/E ratio: 125.5457195327682
Shares outstanding: 433887294
Book value: 644242424.242424
P/B ratio: 2.952627458437635
Market cap (USD): 1902207871.708609
Debt to equity: 2.5484477892756363
Current ratio: 0.3956521739130435
Quick ratio: 0.3956521739130435
Effective tax rate (%): 19.35483870967742
Interest coverage ratio: 1.135678391959799
COGS to revenue (%): 0
SG&A to revenue (%): 10.306122448979592
Free cash flow (dilution-adjusted): 17575757.575757578
Buyback yield (%): 3.2179512093564733
Retained earnings: 86666666.66666667
Receivables turnover: 7.2592592592592595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.127853881278538
FCF margin (%): 2.9591836734693877
Revenue growth (%): -0.9075208038938376
Rule of 40 score: 2.05166286957555
Financial ratios for CNU.AX — annual report dated 2024-06-30
Total revenue: 615853658.5365855
Gross profit: 615853658.5365855
Operating income: 145121951.2195122
Net income: -5487804.87804878
Capital expenditures: 269512195.1219512
Depreciation & amortization: 281707317.0731707
Net tangible assets: 426219512.195122
Owner earnings: 6707317.0731707215
Capex to operating income (%): 185.71428571428572
Buffett classification: The Gruesome
Stock price: 4.28
Shares outstanding: 433887294
Book value: 512804878.0487809
P/B ratio: 3.621333762241139
Market cap (USD): 1857037618.3200002
Debt to equity: 3.32580261593341
Current ratio: 0.37037037037037035
Quick ratio: 0.37037037037037035
Effective tax rate (%): 142.8571428571429
Interest coverage ratio: 1.072072072072072
COGS to revenue (%): 0
SG&A to revenue (%): 10.297029702970297
Free cash flow (dilution-adjusted): 43292682.92682927
Buyback yield (%): 0.36118369423440205
Retained earnings: -35975609.75609756
Receivables turnover: 7.01388888888889
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.349415204678362
FCF margin (%): 7.029702970297029
Revenue growth (%): 3.6896465903434588
Rule of 40 score: 10.719349560640488
Financial ratios for CSCI.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 108.66141732283464
Shares outstanding: 1061386
Market cap (USD): 115331707.08661416
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSCI.TO — annual report dated 2022-12-31
Total revenue: 10714705.88235294
Gross profit: 6291176.470588235
Operating income: 3176470.588235294
Net income: 2535294.117647059
Capital expenditures: 223529.41176470587
Operating cash flow: 3844852.9411764704
Depreciation & amortization: 1079411.7647058822
Net tangible assets: 17486532.06617647
Owner earnings: 3391176.4705882347
Return on net tangible assets (%): 19.393076098534472
Capex to operating income (%): 7.037037037037037
Buffett classification: The Great
Stock price: 37.94117647058823
P/E ratio: 15.883850812064965
Shares outstanding: 1061386
Book value: 17493351.904411767
P/B ratio: 2.302030722840243
Market cap (USD): 40270233.52941176
Debt to equity: 0.08111213647402678
Current ratio: 9.800036381725624
Quick ratio: 8.011682496662392
Effective tax rate (%): 23.85159010600707
Interest coverage ratio: 30.209790209790214
COGS to revenue (%): 41.284655503705736
R&D to revenue (%): 9.408454570409003
SG&A to revenue (%): 19.660993686522094
Free cash flow (dilution-adjusted): 3570588.235294117
Buyback yield (%): 0
Retained earnings: 5894521.161764706
Inventory turnover: 2.173230838285757
Receivables turnover: 6.854897065878728
Capitalized R&D asset: 1008088.2352941176
ROCI (R&D-adjusted, %): 18.94574466522878
FCF margin (%): 33.324183365358216
Rule of 40 score: 33.324183365358216
Financial ratios for CSCI.TO — annual report dated 2023-12-31
Total revenue: 5411363.636363636
Gross profit: 2225757.5757575757
Operating income: -3506818.1818181816
Net income: -2640151.515151515
Capital expenditures: 546969.6969696969
Operating cash flow: -1956060.606060606
Depreciation & amortization: 1110044.9318181819
Net tangible assets: 15930303.03030303
Owner earnings: -2077076.2803030303
Return on net tangible assets (%): -13.03852334981929
Buffett classification: The Gruesome
Stock price: 23.363636363636363
Shares outstanding: 1061386
Book value: 15935606.06060606
P/B ratio: 1.5561276082719278
Market cap (USD): 24797836.545454547
Debt to equity: 0.08072260518183978
Current ratio: 8.594202898550725
Quick ratio: 5.536231884057972
Interest coverage ratio: -34.036764705882355
COGS to revenue (%): 58.86882262354754
R&D to revenue (%): 28.559428811423775
SG&A to revenue (%): 77.37645247095058
Free cash flow (dilution-adjusted): -2648484.848484848
Buyback yield (%): 0
Retained earnings: 3300000
Inventory turnover: 1.0488899975056125
Receivables turnover: 24.63103448275862
Capitalized R&D asset: 2220873.663101604
ROCI (R&D-adjusted, %): -14.636222553836065
Rosenberg metric: -4.032800654244856
FCF margin (%): -48.94302113957721
Revenue growth (%): -49.49591994609837
Rule of 40 score: -98.43894108567558